- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Shree Ganesh Biotech (India) Ltd — Board Meeting, 29-01-2026: Board Meeting
29-01-2026 | 04:12 pm
29-01-2026 | 04:12 pm
Shree Ganesh Bio-Tech's board approved Q3 FY26 results. Revenue for the quarter was ₹0.70 Cr, with PAT at ₹0.32 Cr. For 9M FY26, revenue hit ₹2.85 Cr and PAT was ₹0.66 Cr.
No comments yet. Be the first to comment!